Validations: Biosimilar Process & Analytical Comparability
Host Cell Proteins & DNA: Assays and Limits That Stand In the pharmaceutical industry, particularly within the realm of biosimilars, the assessment of host cell proteins (HCPs) and DNA is critical during the development and commercialization phases. Regulatory bodies like the FDA, EMA, and MHRA have established stringent guidelines for biosimilar analytical comparability and, specifically, for the characterization of HCPs…
CQA Mapping for Biosimilars: Building the Target Product Profile CQA Mapping for Biosimilars: Building the Target Product Profile Understanding CQA Mapping in the Context of Biosimilars Biosimilars are biologic products highly similar to already approved reference products, differing only in minor clinically inactive components. As biosimilars continue to permeate the pharmaceutical market, rigorous validation processes become essential to demonstrate that…
Fingerprint Analytics: Similarity Metrics That Convince Reviewers Fingerprint Analytics: Similarity Metrics That Convince Reviewers Fingerprint analytics is an essential aspect of demonstrating biological product comparability in the context of biosimilar analytical comparability. This technology offers sophisticated methods to evaluate product similarities amid variations throughout the manufacturing process. Understanding the fundamental components and methodologies involved in fingerprint analytics is crucial for…
Mass Spec, CE-SDS, and Peptide Mapping: Choosing the Right Stack Mass Spec, CE-SDS, and Peptide Mapping: Choosing the Right Stack The biopharmaceutical industry faces increasing pressure to ensure that biosimilars meet rigorous regulatory standards for quality and comparability. As such, analytical strategies including mass spectrometry (Mass Spec), capillary electrophoresis sodium dodecyl sulfate (CE-SDS), and peptide mapping are essential to establishing…
Glycan Profiling: HILIC, Exoglycosidase Maps, and Specs Glycan Profiling: HILIC, Exoglycosidase Maps, and Specs In the pursuit of ensuring biosimilar products are comparable to their reference biologics, understanding glycan profiling becomes crucial. This comprehensive tutorial outlines the methodologies and considerations involved in biosimilar analytical comparability, including CQA mapping, fingerprint analytics, and practical steps for implementing these strategies in compliance with…